AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

The small, Ireland-based company GH Research said its inhaled version of mebufotenin — a molecular cousin to psilocybin — was ...

Biotech investing can be tricky. Often, the drugs that these fledgling companies produce don’t pan out, and shareholders take ...

This is common. Those of us in research routinely store patient samples — blood, fluids, tissue, scrapings, and other ...

The inhaled mebufotenin candidate, dubbed GH001, was evaluated in the midstage study of 81 patients with treatment-resistant depression. The 40 patients who received GH001 saw an average 15.2 point ...

The rare disease biotech is laying off 43 employees—equivalent to 30% of the company’s total staffers—along with the discontinuation of its “research efforts” and the closure of a ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

Gladstone Institutes hopes to buy 103,400 square feet of life sciences research offices near its hub in San Francisco’s ...

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...

Purple Biotech (PPBT) announced that it has entered into a Research Collaboration Agreement with the Icahn School of Medicine at Mount Sinai in New York, NY, to explore the immunoregulation of NK ...

Analysts at Zacks Small Cap boosted their Q1 2025 earnings per share (EPS) estimates for shares of Evaxion Biotech A/S in a research report issued on Wednesday, February 5th. Zacks Small Cap analyst B ...